Fully Human Antibody Targeting Human CD123 For Cancer Threpeutics Development
Technology
E-131-2018
Patent ID
E-131-2018-0-US-03
Country
US
Application Type
ORD
Patent Status
Issued
Patent Number
10844128
Publication Number
US-2020-0010555-A1
Application Number
16/578,063
IC
NCI
Date Filed
Date Issued